Aiming to offer more safety for patients, an expert panel of the health ministry has recommended that 343 of them should be “prohibited”
Decision was taken after reviewing 349 fixed drug combinations (FDCs)by the expert panel (Drugs Technical Advisory Board (DTAB))
Panel reviewed the drugs and offered review for banning 343 fixed drug combination. According to a senior government official, the expert sub-committee has clearly stated in its report that “for most FDCs, their use would lead to unnecessary overuse and the patients would be exposed to the risk of multiple ingredients when one would suffice”.
The official added that according to panel, while 343 FDCs should be banned, “three FDCs should be restricted for specific indications or diseases”, and other “three FDCs should be restricted to specific quantities of ingredients and for specific indications”. Total 344 FDCs were banned on March 10, 2016, by the central government on the suggestion of the panel formed under the chairmanship of C K Kokate. Some that were banned were: Cefixime + Azithromycin, Ofloxacin + Ornidazole Suspension, and Metronidazole + Norfloxacin.